24
Participants
Start Date
June 30, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
January 31, 2014
SL TNX-102 2.4 mg at pH 3.5
1 dose of 2.4 mg TNX-102 sublingual solution (2.4 mg/mL) in PBS at pH 3.5, administered as 1 mL held under the tongue for 90 seconds without swallowing
SL TNX-102 2.4 mg at pH 7.1
1 dose of 2.4 mg TNX-102 sublingual solution (2.4 mg/mL) in PBS at pH 7.1, administered as 1 mL held under the tongue for 90 seconds without swallowing
Cyclobenzaprine Tablet
1 x 5 mg cyclobenzaprine tablet, swallowed with 240 mL of room-temperature water
Cyclobenzaprine IV
1 dose of 2.4 mg cyclobenzaprine USP in PBS (0.6 mg/mL) at pH 7.4, administered intravenously as a 4 mL bolus injection over 30 seconds
PharmaNet, Inc., Québec
Tonix Pharmaceuticals, Inc.
INDUSTRY